Skip to main content
CBIO filings

Corporate insider profile

Jan Pinkas Filing Activity

Latest reported as Chief Scientific Officer of CRESCENT BIOPHARMA, INC. (CBIO).

Purchase filings
0
Reported companies
1
Net open-market value
-$23,171.12
Latest transaction
Jun 22, 2026

Affiliated corporations

Reported company relationships

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Jun 22, 2026CRESCENT BIOPHARMA, INC. (CBIO)Chief Scientific OfficerSale1,288$17.99$23,171